HC Wainwright & Co. Downgrades Crescent Biopharma to Neutral

Benzinga Newsdesk www.benzinga.com Negative 87.2%

Neg 87.2% Neu 0% Pos 0%

HC Wainwright & Co. analyst Mitchell S. Kapoor downgrades Crescent Biopharma (NASDAQ:CBIO) from Buy to Neutral.

Comments

No comments yet. Be the first!

HC Wainwright &amp; Co. Downgrades Crescent Biopharma to Neutral